Related Experiment Video
Updated: Jun 22, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Expression and function of bcl-2 proteins in melanoma
Jürgen Eberle1, Amir M Hossini
1Charité - Universitätsmedizin Berlin, Department of Dermatology and Allergy, Skin Cancer Center Charité, Berlin, Germany.
Abstract:
Bcl-2 proteins are critical regulators of mitochondrial membrane permeability and the proapoptotic mitochondrial pathway. The family encloses pro- and antiapoptotic factors encoded by over 15 genes, which frequently give rise to alternative splice products. Antiapoptotic, proapoptotic multidomain, and proapoptotic BH3-only proteins are characterized by the presence of at least one of four Bcl-2 homology domains (BH 1-4). Their expression and activities are controlled by survival pathways as MAP kinases and protein kinase B/Akt, which are in touch with a number of transcription factors. In melanoma, the mitochondrial apoptosis pathways and Bcl-2 proteins appear of particular importance for apoptosis resistance, which has been addressed in clinical trials applying antisense-Bcl-2. Overexpression or induction of proapoptotic Bcl-2 proteins as well as the use of small molecule mimetics for the proapoptotic BH3 domain are further promising strategies.
Insights
Bcl-2 proteins regulate cell death pathways. Targeting these proteins, particularly in melanoma, offers promising therapeutic strategies for overcoming apoptosis resistance.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Biology
Background:
- Bcl-2 proteins are key regulators of mitochondrial membrane permeability and apoptosis.
- The Bcl-2 family includes pro- and antiapoptotic proteins with conserved Bcl-2 homology (BH) domains.
- Survival pathways like MAP kinases and Akt influence Bcl-2 protein expression and activity.
Purpose of the Study:
- To review the role of Bcl-2 proteins in apoptosis resistance, especially in melanoma.
- To discuss current and emerging therapeutic strategies targeting Bcl-2 proteins.
Main Methods:
- Literature review of Bcl-2 protein function and regulation.
- Analysis of Bcl-2 protein involvement in melanoma apoptosis resistance.
- Overview of therapeutic approaches including antisense therapy and small molecule mimetics.
Main Results:
- Bcl-2 proteins are crucial for maintaining mitochondrial integrity and controlling apoptosis.
- Dysregulation of Bcl-2 proteins contributes significantly to apoptosis resistance in melanoma.
- Clinical trials are investigating antisense-Bcl-2 strategies for melanoma treatment.
Conclusions:
- Bcl-2 proteins are vital targets for cancer therapy, particularly in melanoma.
- Strategies like antisense therapy and BH3 mimetics show promise in overcoming apoptosis resistance.
- Further research into Bcl-2 family interactions may yield novel therapeutic interventions.
More Related Videos
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...